Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 61

Sort by

Sort Order Select

Journal Articles

Impact of Cooperating Myeloid Gene Mutations on Disease Progression and Survival in Japanese MPN Patients: A Multicenter Study

Blood (2024) 144 (Supplement 1): 1805.

https://doi.org/10.1182/blood-2024-208908

Published: 2024

Journal Articles

Soluble B-Cell Maturation Antigen Levels for Disease Monitoring in Oligo- and Non-Secretory Relapsed Multiple Myeloma

Daisuke Ikeda, Shuichi Aikawa, Chiho Misono, Mitsuaki Oura, Fuminari Fujii, Hajime Sakuma, Masanori Toho, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Tomohisa Watari, Yoshihito Otsuka, Kosei Matsue

Blood (2024) 144 (Supplement 1): 366.

https://doi.org/10.1182/blood-2024-207595

Published: 2024

Journal Articles

Total Diffusion Volume Evaluated By Whole-Body Diffusion Weighted Magnetic Resonance Image for the Assessment of Tumor Burden in Multiple Myeloma; Relations with Measurable Residual Disease Evaluated By Next-Generation Flow Cytometry and Bone Marrow CD138 Staining Assessed By Qupath

Kentaro Narita, Youichi Machida, Daisuke Ikeda, Rikako Tabata, Atsushi Uehara, Mitsuaki Oura, Fuminari Fujii, Hajime Sakuma, Masami Takeuchi, Kosei Matsue

Blood (2024) 144 (Supplement 1): 491.

https://doi.org/10.1182/blood-2024-199873

Published: 2024

Journal Articles

Soluble BCMA As a Surrogate Biomarker for Tumor Burden in Multiple Myeloma: Correlations with Various Biomarkers and Treatment Responses

Rikako Tabata, Mitsuaki Oura, Daisuke Ikeda, Shuichi Aikawa, Chiho Misono, Fuminari Fujii, Hajime Sakuma, Masanori Toho, Atsushi Uehara, Kentaro Narita, Masami Takeuchi, Tomohisa Watari, Yoshihito Otsuka, Kosei Matsue

Blood (2024) 144 (Supplement 1): 3313.

https://doi.org/10.1182/blood-2024-211840

Published: 2024

Journal Articles

Simultaneous Assessment of Total Metabolic Tumor Volume and Intratumoral CD4+ T-Cell Infiltration Identifies Early Progression of Follicular Lymphoma on Watch-and-Wait Approach

Fuminari Fujii, Daisuke Ikeda, Hajime Sakuma, Mitsuaki Oura, Masanori Toho, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Kosei Matsue

Blood (2024) 144 (Supplement 1): 3042.

https://doi.org/10.1182/blood-2024-210742

Published: 2024

Journal Articles

Serum BCMA Is a Better Reflector of Tumor Volume Than IgM in the Induction Period of Waldenström Macroglobulinemia

Mitsuaki Oura, Daisuke Ikeda, Chiho Misono, Shuichi Aikawa, Fuminari Fujii, Hajime Sakuma, Masanori Toho, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Tomohisa Watari, Yoshihito Otsuka, Masami Takeuchi, Kosei Matsue

Blood (2024) 144 (Supplement 1): 3035.

https://doi.org/10.1182/blood-2024-202282

Published: 2024

Journal Articles

Prognostic Value of t(11;14)(q13;32) in Newly Diagnosed Myeloma Patients in Novel Agent Era; Matched-Pair Analysis

Yuka Shimada, Daisuke Miura, Ami Inokuchi, Daisuke Ikeda, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Kosei Matsue

Blood (2024) 144 (Supplement 1): 1931.

https://doi.org/10.1182/blood-2024-194325

Published: 2024

Journal Articles

Different Patterns of Antigen Expression in Bone Marrow and Circulating Tumor Plasma Cells in Patients with MGUS and Smoldering Multiple Myeloma

Atsushi Uehara, Fuminari Fujii, Hajime Sakuma, Mitsuaki Oura, Masanori Toho, Daisuke Ikeda, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Kosei Matsue

Blood (2024) 144 (Supplement 1): 4682.

https://doi.org/10.1182/blood-2024-206782

Published: 2024

Journal Articles

Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma

Blood blood.2024026028.

https://doi.org/10.1182/blood.2024026028

Published: 2024

Includes: Supplemental data

Journal Articles

Development of a Novel Nomogram for Predicting Delayed Methotrexate Excretion in Adult Patients with Hematologic Malignancies

Daisuke Ikeda, Tatsuya Isezaki, Satoshi Yuyama, Kentaro Narita, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Masami Takeuchi, Kosei Matsue

Blood (2023) 142 (Supplement 1): 4498.

https://doi.org/10.1182/blood-2023-190539

Published: 2023

Journal Articles

Lower Prognostic Performance of the International Metabolic Prognostic Index Compared to the Conventional IPI and NCCN-IPI in a Real-World Cohort of Diffuse Large B-Cell Lymphoma

Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Kosei Matsue

Blood (2023) 142 (Supplement 1): 4493.

https://doi.org/10.1182/blood-2023-189352

Published: 2023

Journal Articles

A Prognostic Model Integrating Circulating Clonal Plasma Cells into R-ISS and PET-CT Based Tumor Burden in Transplant-Ineligible Multiple Myeloma

Daisuke Ikeda, Toshiki Terao, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Kosei Matsue

Blood (2023) 142 (Supplement 1): 1972.

https://doi.org/10.1182/blood-2023-189137

Published: 2023

Journal Articles

Red Cell Distribution Width-to-Albumin Ratio Is a Simple but Robust Prognostic Biomarker in Peripheral T-Cell Lymphoma

Mitusaki Oura, Daisuke Ikeda, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Kosei Matsue

Blood (2023) 142 (Supplement 1): 6193.

https://doi.org/10.1182/blood-2023-186462

Published: 2023

Journal Articles

Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy

Daisuke Ikeda, Toshiki Terao, Ami Fukumoto, Ayumi Kuzume, Yuya Kamura, Rikako Tabata, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Takeshi Yamashita, Hiroyuki Takamatsu, Kosei Matsue

Blood (2022) 140 (Supplement 1): 9277–9278.

https://doi.org/10.1182/blood-2022-168823

Published: 2022

Journal Articles

Prognostic Relevance of Tumor-Infiltrating T-Lymphocytes on Total Metabolic Tumor Volume-Based Risk Stratification of Patients with Diffuse Large B-Cell Lymphoma

Daisuke Ikeda, Kentaro Narita, Ami Fukumoto, Ayumi Kuzume, Yuya Kamura, Rikako Tabata, Toshiki Terao, Takafumi Tsushima, Daisuke Miura, Masami Takeuchi, Youichi Machida, Kosei Matsue

Blood (2021) 138 (Supplement 1): 3510.

https://doi.org/10.1182/blood-2021-147172

Published: 2021

Journal Articles

Loss of Spleen Visualization on Whole-Body Diffusion-Weighted Imaging in Patients with Multiple Myeloma Is Associated with Poor Prognosis and High Tumor Burden

Toshiki Terao, Youichi Machida, Ukihide Tateishi, Takafumi Tsushima, Kentaro Narita, Daisuke Ikeda, Ami Fukumoto, Ayumi Kuzume, Rikako Tabata, Daisuke Miura, Masami Takeuchi, Kosei Matsue

Blood (2021) 138 (Supplement 1): 3797.

https://doi.org/10.1182/blood-2021-147250

Published: 2021

Journal Articles

Carfilzomib Is Safe in Elderly Patients with Multiple Myeloma but Thrombotic Microangiopathy Is Underestimated in Clinical Practice

Toshiki Terao, Takafumi Tsushima, Daisuke Miura, Daisuke Ikeda, Ami Fukumoto, Ayumi Kuzume, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Kosei Matsue

Blood (2021) 138 (Supplement 1): 3798.

https://doi.org/10.1182/blood-2021-146460

Published: 2021

Journal Articles

Total Diffusion Volume Estimated By Whole-Body Diffusion Magnetic Resonance Imaging for the Assessment of Tumor Burden in Multiple Myeloma

Kentaro Narita, MD, Youichi Machida, MD, Ayumi Kuzume, MD, Toshiki Terao, MD, Rikako Tabata, MD, Takafumi Tsushima, MD, Daisuke Miura, MD, Masami Takeuchi, MD, Kosei Matsue, MDPhD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-139164

Published: 2020

Journal Articles

Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Multiple Myeloma and Stratification of Revised International Staging System Stage II

Toshiki Terao, MD, Yoichi Machida, MD, Takafumi Tsushima, MD, Akihiro Kitadate, MD PhD, Daisuke Miura, MD, Kentaro Narita, MD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2019) 134 (Supplement_1): 1861.

https://doi.org/10.1182/blood-2019-130845

Published: 2019

Journal Articles

Clinical Features, Diagnosis, and Prognosis of 22 Cases of Neurolymphomatosis : A Single-Institution Experience over 12 Years

Kentaro Narita, MD, Toshiki Terao, MD, Takafumi Tsushima, MD, Akihiro Kitadate, MD PhD, Daisuke Miura, MD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2019) 134 (Supplement_1): 1630.

https://doi.org/10.1182/blood-2019-126706

Published: 2019

NARROW

Impact of Cooperating Myeloid Gene Mutations on Disease Progression and Survival in Japanese MPN Patients: A Multicenter Study

Soluble B-Cell Maturation Antigen Levels for Disease Monitoring in Oligo- and Non-Secretory Relapsed Multiple Myeloma

Total Diffusion Volume Evaluated By Whole-Body Diffusion Weighted Magnetic Resonance Image for the Assessment of Tumor Burden in Multiple Myeloma; Relations with Measurable Residual Disease Evaluated By Next-Generation Flow Cytometry and Bone Marrow CD138 Staining Assessed By Qupath

Soluble BCMA As a Surrogate Biomarker for Tumor Burden in Multiple Myeloma: Correlations with Various Biomarkers and Treatment Responses

Simultaneous Assessment of Total Metabolic Tumor Volume and Intratumoral CD4+ T-Cell Infiltration Identifies Early Progression of Follicular Lymphoma on Watch-and-Wait Approach

Serum BCMA Is a Better Reflector of Tumor Volume Than IgM in the Induction Period of Waldenström Macroglobulinemia

Prognostic Value of t(11;14)(q13;32) in Newly Diagnosed Myeloma Patients in Novel Agent Era; Matched-Pair Analysis

Different Patterns of Antigen Expression in Bone Marrow and Circulating Tumor Plasma Cells in Patients with MGUS and Smoldering Multiple Myeloma

Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma

Development of a Novel Nomogram for Predicting Delayed Methotrexate Excretion in Adult Patients with Hematologic Malignancies

Lower Prognostic Performance of the International Metabolic Prognostic Index Compared to the Conventional IPI and NCCN-IPI in a Real-World Cohort of Diffuse Large B-Cell Lymphoma

A Prognostic Model Integrating Circulating Clonal Plasma Cells into R-ISS and PET-CT Based Tumor Burden in Transplant-Ineligible Multiple Myeloma

Red Cell Distribution Width-to-Albumin Ratio Is a Simple but Robust Prognostic Biomarker in Peripheral T-Cell Lymphoma

Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy

Prognostic Relevance of Tumor-Infiltrating T-Lymphocytes on Total Metabolic Tumor Volume-Based Risk Stratification of Patients with Diffuse Large B-Cell Lymphoma

Loss of Spleen Visualization on Whole-Body Diffusion-Weighted Imaging in Patients with Multiple Myeloma Is Associated with Poor Prognosis and High Tumor Burden

Carfilzomib Is Safe in Elderly Patients with Multiple Myeloma but Thrombotic Microangiopathy Is Underestimated in Clinical Practice

Total Diffusion Volume Estimated By Whole-Body Diffusion Magnetic Resonance Imaging for the Assessment of Tumor Burden in Multiple Myeloma

Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Multiple Myeloma and Stratification of Revised International Staging System Stage II

Clinical Features, Diagnosis, and Prognosis of 22 Cases of Neurolymphomatosis : A Single-Institution Experience over 12 Years

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only